|
RPAP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.120200E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.927200E-01 |
| Normal-vs-Stage2 |
5.488800E-01 |
| Normal-vs-Stage3 |
1.596640E-01 |
| Normal-vs-Stage4 |
2.177800E-01 |
| Stage1-vs-Stage2 |
6.431400E-01 |
| Stage1-vs-Stage3 |
2.137800E-01 |
| Stage1-vs-Stage4 |
9.709600E-02 |
| Stage2-vs-Stage3 |
5.265800E-01 |
| Stage2-vs-Stage4 |
3.601600E-01 |
| Stage3-vs-Stage4 |
7.005200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.788100E-02 |
| Normal-vs-AfricanAmerican |
4.392600E-01 |
| Normal-vs-Asian |
2.890800E-01 |
| Caucasian-vs-AfricanAmerican |
5.545200E-01 |
| Caucasian-vs-Asian |
1.873770E-01 |
| AfricanAmerican-vs-Asian |
1.664040E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.367000E-01 |
| Normal-vs-Female |
2.495900E-03 |
| Male-vs-Female |
1.080410E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.189240E-01 |
| Normal-vs-Extreme_Weight |
8.495000E-01 |
| Normal-vs-Obese |
5.763800E-01 |
| Normal-vs-Extreme_Obese |
2.709600E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.652990E-01 |
| Normal_Weight-vs-Obese |
3.637200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.228200E-01 |
| Extreme_Weight-vs-Obese |
7.019600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.507400E-01 |
| Obese-vs-Extreme_Obese |
5.245400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.435700E-03 |
| Normal-vs-Age(41-60Yrs) |
2.644000E-02 |
| Normal-vs-Age(61-80Yrs) |
3.673800E-01 |
| Normal-vs-Age(81-100Yrs) |
3.817800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.008830E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.643540E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.382500E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.633620E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.658300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.311600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.646310E-02 |
| Normal-VS-Type2 PRCC |
8.990400E-01 |
| Normal-VS-KIRP CIMP |
7.255500E-02 |
| Normal-VS-Unclassified PRCC |
4.458400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.625500E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.912200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.322800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.996100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.552600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.181600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.655200E-01 |
| Normal-vs-N1 |
2.104200E-01 |
| Normal-vs-N2 |
2.579600E-01 |
| N0-vs-N1 |
1.568240E-01 |
| N0-vs-N2 |
2.702000E-02 |
| N1-vs-N2 |
4.293200E-01 |
|
|
